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In these studies, we examined the possibility that cell-
free preparations from murine keratinocytes possess 5-
lipoxygenase activity in addition to the well-established 
cyclooxygenase pathway of arachidonic acid (AA) in 
these cells. Our data demonstrated that the high-speed 
(105,000 g) supernatant preparations of the murine 
keratinocytes metabolized [14C]AA into labeled lipoxy-
genase products. Portions of these radioactive metabo-
lites cochromatographed and comigrated with 12-HETE 
(a marker for 12-lipoxygenase pathway) and with au-
thentic L TB4 (a marker for 5-lipoxygenase pathway) on 
silicic acid column chromatography and by thin-layer 
chromatography (TLC) in two solvent systems respec-
tively. Identity of the novel 14C which comigrated with 
L TB4 on both TLC and column chromatography was 
verified further by cochromatography of the free acid 
with authentic L TR. on a reverse phase (RP) and the 
methyl esters on a straight phase high-pressure liquid 
chromatography. Incubation of the cell-free prepara-
tions with [14C]AA in the presence of ETYA, NDGA 
(inhibitors of cyclooxygenase and lipoxygenase path-
ways) as well as with 15-HETE (an inhibitor of lipoxy-
genase pathway) resulted in decreased formation of [~<~C] 
12-HETE and the [14C]LTB.-like metabolite. On the 
contrary, incubations of the cell-free extracts with [1 '1C] 
AA in the presence of indomethacin (a cyclooxygenase 
inhibitor) resulted in increased biosynthesis of the la-
beled lipoxygenase metabolites. These data indicate the 
existence of enzymes in soluble fraction of murine ker-
atinocyte which can catalyze the transformation of [14 C] 
AA into products of both the 12- and 5-lipoxyganase 
pathways. 
Manuscript received December 19, 1983; accepted for publication 
April 25, 1984. 
Supported in part by Research Grants AM-30679 and AM-26009 of 
the U.S. Public Health Service. 
* Presented in part at the Annual Meeting of The Society of Inves-
tigative Dermatology (Western Section), Carmel, California, February 
9- 11, 1983. 
Reprint requests to: Dr. Vincent A. Ziboh, Department of Derma-
tology, TB 192, University of California, Davis, California 95616. 
Abbreviations: 
AA: arachidonic acid 
ETYA: 5,8,11,13-eicosatetrayn oic acid 
GLS-MS: gas liquid chromatography-mass spectrometry 
H: homogenate 
HETE: hydroxyeicosatetraenoic ac id 
HPLC: high-pressure liquid chromatography 
HSP: high-speed pellet 
HSS: high-speed supernatant 
L T: leukotriene 
NDGA: nor-dihydroguaretic acid 
PG: prostaglandin 
RP: reverse phase 
SP: straight phase 
TLC: thin-layer chromatography 
TX: thromboxane 
Although most studies of the metabolism of arachidonic acid 
(AA) by skin preparations in the last decade have focused 
mainly on the metabolites of AA via the cyclooxygenase path-
way, particularly the prostaglandins (PGs), limited interest had 
been exerted on the novel metabolites of AA via the lipoxygen-
ase pathway. These include mono- and dihydroxyeicosatetrae-
noic acids (HETEs) and leukotrienes. Recent progress in the 
elucidation of the chemical structures [1-5) and the biologic 
properties of these novel lipoxygenase products has led to a 
greater understanding of a variety of inf1ammatory and prolif-
erative disorders in a variety of mammalian systems (6-12). As 
a first step in our goal to establish whether or not the enzymatic 
transformation of AA via the 5-lipoxygenase pathway into 
leukotrienes occurs in mammalian epidermis, we investigated 
whether or not enzymatic transformation, via the above path-
way, exists in cultured murine keratinocytes and its subcellular 
localization. The present investigation is an extension of a 
previous study (13) in which we demonstrated that the chal-
lenge of whole murine keratinocytes, which were previously 
labeled with [14 C]AA with calcium ionophore (A23187), resulted 
in the formation of several radioactive metabolites of AA. A 
small portion of these 14 C-labeled metabolites (less than 1% of 
the incubated [14C)AA) comigrated on both silicic acid column 
and thin-layer chromatography (TLC) with authentic leuko-
triene B,, (L TB,) (58, 12R-dihydroxy-6,14-cis,8,10-transeicos-
atetraenoic acid). Among the other radioactive monohydroxy 
metaboli tes of AA that were generated was 12-hydroxy-
5,8,10,14-eiosatetraenoic acid (12-HETE) , a metabolite which 
has previously been described in murine keratinocytes (14]. 
What had not been reported was whether these cells are also 
capable of transforming AA into the dihydroxy-ETEs, partic-
ularly the L TB,. The present studies were designed, therefore: 
(i) to determine whether homogenates prepared from murine 
keratinocytes can transform [14C]AA into radiolabeled dihy-
droxymetabolites of AA, particularly L TB4 ; and (ii) to deter-
mine the subcellular location of such transforming enzymes. 
MATERIALS AND METHODS 
Chemicals 
[1-"C]AA (58.0 mCi/mmol) was obtained from Amersham Corpo-
ration. The radiolabeled fatty acid was purified by chromatography on 
silicic ac id column (Silicar CC-4) using n-hexane/ diethyl ether (9:1) as 
eluting solvent. Additional confirmation of purity was by TLC. The 
purity of the purified [14C]AA generally exceeded 98%. Authentic L TB,, 
which had been characterized previously by gas liquid chromatography-
mass spectrometry (GLC-MS) was generously supplied by Dr. Rokach 
of Merck Frosst (Pointe Claire, Canada). 12-HETE which was used as 
a standard in our experiments was biosynthesized by the incubation of 
AA with human platelets treated with indomethacin. The incubation 
of platelets with indomethacin inhibits formation of thromboxane A. 
(TXA2) while enhancing the formation of 12-HETE. The isolated 12: 
HETE was purified according to McGuire et a l [15] and confirmed 
by high-pressure liquid chromatography (HPLC) as 12-HETE. Nor-
dihydroguaretic acid (NDGA) and 5,8,11,13-eicosatetraynoic acid 
(ETYA) were gifts from Dr. James Hamilton, Hoffmann La Roche, 
Nutley, New Jersey. 15-HETE was a gift from Dr. Robert Bryant of 
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George Washington University, Washington , D.C. All the compounds 
were added in ethanol at a concentration of 0.1 % of t he incubation 
medium. Ethanol at this concentration did not inhibit the activity of 
the lipoxygenase enzymes. All reagents for t hese experiments were of 
analytical grade. 
Cell Cultures 
Murine keratinocytes we re prepared from neonatal BALB/c mice as 
reported previously [ 16]. Briefly, freshly dissociated keratinocytes were 
inoculated into T-flasks containing M-199 medium with 13% fetal calf 
serum, penicillin (50 IU/ m), and streptomycin (50 11g/ml) . The flasks 
were gassed with 5% C02 in a ir, closed, and incubated at 33· c. The 
medium was changed every second day. Previous characterization of 
these cells showed that t hey were devoid of fibrob lasts [16] . 
Preparation of S u.bcel/ulor Fractions 
Two-day-old keratinocytes (2 X 107) were harvested by centrifuga-
tion at 200 g for 5 min and washed once with cold 50 mM phosphate 
buffer (pH 7.4) containing 1 mM EDTA. The cells were resuspended in 
t he same buffer and homogenized with a Potter-Elvehjem glass tissue 
grinder. The homogenate was centrifuged at 800 g for 10 min and the 
resulting pellet fraction which conta ined cell debris and nuclear mate-
rials was discarded. A portion of the resulting supernatant fraction 
designated as homogenate (H) was furt her centrifuged at 100,000 g for 
60 min at 4 · c, in a Beckman L 50-Ultracentrifuge. This provided the 
high-speed pellet (HSP) and the high-speed supernatant (HSS) frac-
tions. All 3 fractions were stored in an ice bucket and subsequently 
used for incubations. Protein contents of the subcellula r fractions were 
determined by t he method of Lowry eta! [1 7] with bovine serum 
albumin used as standard. 
Incubations 
In preliminary experiments 2.0-ml a liquots of each of the 3 subcel-
lular fractions ranging from 400-2000 f.l g of protein in 50 mM phosphate 
buffer (pH 7.4) containing EDTA (1 mM) and CaCl2 (1.5 mM) were 
incubated respectively with ["C]AA (0.2 llCi) at 37•c for various t ime 
interva ls-10, 20, 30 min, respectively. The HSS fractions were incu-
bated additionally with 1 mM reduced glutathione (GSH) to provide a 
reducing equivalent for the transformation of the hydroperoxy acids 
into the hyd roxy ac ids. The effects of 2 inhibi to rs of the lipoxygenase 
a nd cyclooxygenase pathways (ETYA and NDGA) as well as a reported 
lipoxygenase inhibitor (15-HETE) were tested on the ability of the 
ce ll-free preparations to generate "C- labeled metabolites which comi-
grated with authentic 12-HETE and LTB, on 3 chromatographic 
systems (column, TLC, and HPLC) . Furthermore, the effect of blocking 
on ly the cyclooxygenase pathway on t he metabolism of AA via the 
lipoxygenase pathway was tested. In t hese experiments, HSS fractions 
were incubated with ["C]AA in t he presence of indomethacin (15.0 
11M). All incubations were stopped by the addition of methanol , and 
the total lipids were extracted by a mixture of chloroform:methanol 
(2:1) according to the method of Folch et a! [18). The lipid extracts 
were dried under vacuum in a rotary evaporator, dissolved in 0.5 ml of 
ch loroform:methanol (6:1) and flooded with nitrogen gas. The extracts 
were stored at - 7o· c un til subjected to chromatographic separations. 
Identification of Radioactive Metabohtes 
Thin Loyer chromatography: In preliminary experiments, portions of 
t he "C-labeled lipid extract were dissolved in a mixture of chloro-
form: methanol (1:1) to which was added aut hentic standards of LTB,, 
12-HETE (lipoxygenase products), PGD2 (cyclooxygenase product) , 
and AA. A portion of the "C-labeled mixture was applied to activated 
silica gel G-coated plates and developed first in t he orga nic phase of 
the fo llowi ng solvent system: ethyl acetate:2,2,4-trimethylpen-
tane:acetic ac id:water (82.5 :37.5:15:75, v/v). Location of t he added 
standards on t he plates was determined by visua lization of the plates 
in a tank conta ining iodine vapor. This first system separates t he 
cyclooxygenase products (PGs) from the lipoxygenase products 
(HETEs and leukotrienes). For further verification, the si lica gels 
co ntaining 14C which comigrated with the authentic LTB,, 12-HETE, 
and AA were eluted with chloroform:methanol (1:1) and dried under 
N2 gas. The mixture was reapplied to a second activated silica G-coated 
plate and developed in a second solvent mixture of: petroleum 
ether:diethyl ether:acetic ac id (50:50:1, v/v). This solvent system effec-
tive ly separates the mono-HETEs from the more polar di-HETEs. 
After visuali zation of t he authentic carriers LTB,, 12-HETE, and AA 
by iodine vapor, the radioactivity on t he entire plate was scanned first 
by a Packard radioscanner to determine the peaks of radioactivity. The 
si lica gel on the entire TLC plate was then scraped in 0.5-cm portions 
directly into scintillation vials which contained 12 ml of Econofluor 
(New England Nuclear, premix scinti llation) and then counted in a 
liquid scintillation spectrometer. 
Column chromatography: Chromatography of another portion of the 
"C-labeled incubation extract was also performed in 5 mm-diameter 
glass columns which were packed with 1 g of activated silicic acid 
(Mallinckrodt, 100 mesh) as reported previously by Borgeat and Sam-
uelsson [3]. Briefly, a portion of the extracted " C containing authentic 
LTB,, 12-HETE, and AA was dissolved in 0.5 ml of a mixture of diethyl 
ether: hexane (25:75) and then carefully applied to the si licic acid-
packed column. Fractions of the "C-labeled extract and standards were 
elu ted with 30 ml mixtures of: (A) diethyl ether: hexane (25:75, v/v); 
(B) diethyl ether:hexane, (45:55 v/ v); and (C) ethyl acetate, respec-
tively. AA and nonpolar lipids eluted in fraction (A) ; monohydroxy-
ETEs (e.g., 12-HETE) eluted in fraction (B); and dihydroxy-ETEs 
(e.g., L TB.) and the more polar di-HETE metabolites eluted in fraction 
(C). 
High-pressure liquid chromatography: To further characterize the 
polar " C- labeled metabolites which were eluted with L TB, from the 
silicic acid column by ethyl acetate, an authentic standard of PGB2 (internal standard) was added to t he vial which contained the ethyl 
acetate eluent. The mixture containing t he "C-labeled metabolites 
authent ic LTB. and PGB2 was dried under N2 and t hen redissolved i~ 
a small amount of the HPLC mobile phase. A portion of this mixture 
was injected first into a reverse phase (RP) HPLC packed with Ult ra-
sphere ODS-column (25 X 0.46 em) which was connected to a guard 
column (4 X 0.46 em) packed with 5-l'm particles of Spherosorb-ODS 
(Altex). The mixture of L TB,, PGB2 , and the eluted 14C were separated 
after the application of the mobile phase of methanol:water:acetic acid 
(65:35:0.02, v/v), which had previously been adjusted to pH 5.7 with 
10% NH.OH. The HPLC was run at a flow rate of 1 ml/min; peaks of 
elu ted nonradioactive L TB, and PGB2 were detected at 280 nm by a 
Beckman 165 variable wavelength detector. Column effluents were 
collected at 1-min intervals simultaneously during the chromatographic 
separation in separate vials by a Gilson fraction collector connected to 
the Beckman HPLC instrument. The vials were subsequently counted 
in a liquid scin ti llation counter. 
The remaining portion of the ethyl acetate effluent was also treated 
with authentic LTB. and PGB2 and methylated with an ethereal 
solut ion of diazomethane. The resulting methyl esters were separated 
on a straight phase (SP)-HPLC system as described by Borgeat et al 
[1 9). This system separates the authent ic LTB, from the nonbiologi-
cally active di-HETE. 
RESULTS 
In preliminary experiments, t he metabolism of ["C]AA into 
lipoxygenase products increased with protein content of the 
cell-free preparations. Typical incubations con tain ed 800-1200 
J..Lg protein of subcellular fraction. Incubation at various times 
revealed maximal formation of lipoxygenase products (using 
LTB, and 12-HETE as markers) between 10- 15 min. 
Thin-Layer Chromatography 
A typical TLC chromatogram on the second solvent mixture: 
petroleum ether:diethyl ether:acetic acid (50:50:1) of the ''C-
labeled extract obtained from t he incubation of the HSS frac-
tion and [''C]AA is s hown in Fig 1. Several "C-labeled metab-
olites of AA were formed including 2 radiometabolites that 
cochromatographed with authentic LTB4 and 12-HETE, re-
spectively. Biosynthesis of the "C-labeled di-HETEs and the 
mono-HETEs by t h e HSS fraction was inhibited by ETYA (50 
J..LM), NDGA, (30 J..LM) , and 15-HETE (15 J..LM), known inhibitors 
of the lipoxygenase pathway. 
Silicic-Acid Column Chromatography 
Results of t he chromatography of the "C-labeled extract 
after the incubation of [' "C]AA with each of the 3 subcellu lar 
fractions- H, HSS, and HSP-are shown in Fig 2. The un-
metabolized ['"C]AA and the labeled nonpolar lipids were 
eluted respectively in the first 30-ml fraction of diethyl 
ether:hexane (25:75, v/v); t he second fraction of diethyl 
ether:hexane (45:55, v/v) e luted approximately 8.5% and 5.7% 
of chromatographed 14C from incubations of [' ''C]AA with HSS 
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F IG 1. Th in-layer chromatographic profi le of "C- labeled lipoxygen-
ase products from ["C]AA incubated with the HSS. T he 105,000 g 
supernatant of homogenates of 2 x 107 ce lls (approx 1100 ;tg protein ) 
was incubated with 0.2 ;tCi of [14C]AA, CaCl2 (1.5 mM), reduced 
glutath ione (1.0 mM), and indomethacin (15 ;tM) at 37' C fo r 15 min . 
The ''C-labeled metaboli tes were extracted by chloroform:methanol 
(2:1) and the ' 'C- labeled residue separated on 2 TLC solvent systems: 
ethyl acetate:tri methylpentane:acetic ac id:water (82.5:37.5:15:75) and 
petroleum ether:diethyl ether: acetic acid (50:50:1 ). Authent ic L TB, , 
12-HETE, and AA were used as carrie rs. 
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F IG 2. Silicic acid column ch romatography of ~<C- l abe led metabo-
lites afte r the incubation of [l- 1'C]A A with 3 subcell ula r fractions of 
mu ri ne ke ratinocytes. Each subcellular fract ion (approx 900- 1200 ;tg 
protein ) was incubated with [1'C]AA (0.2 ;tCi), CaC12 (1.5 mM), and 
reduced glutath ione (l mM). Details of lipid extraction after each 
subcellular incubation and chromatography on activated silicic acid 
colu mns we re as descr ibed unde r Materials and Methods. Separation 
on the colum n was achieved by eluting with 30 ml of 3 solvent mixtures: 
(A) diethyl ether:hexane (25:75, v/v; (B) diethyl ether:hexane (44:55, 
v/ v), and (C) ethyl acetate. T he separate fractions were collected and 
assayed for radioactivity in the scinti llation counte r. Each vertical bar 
rep resents the mean ± SE of dup licate resul ts from 4 experiments. T he 
data are expressed as percent of chromatographed ' 'C per mg of 
subcella r protein . 
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and H fractions, respectively. This second 30-ml eluen t gener-
ally contains the monohydroxy-ETEs (12-HET E, 5-HETE) . 
T he t hi rd solvent of ethyl acetate eluted approximately 4.2% 
and 3.0% of chromatographed 1''C from incubations of t he HSS 
and H fract ions, respectively. T he "C eluted from incubations 
of HSP wit h t he last two solvents was less t han 1%, t hus t his 
pellet fraction was no longe r investigated fo r t he fo rmation of 
lipoxygenase products. 
High-Pressure Liquid Chromatography 
To further characterize t he polar "C-labeled metaboli tes t hat 
were generated by t he incubations of [' ''C]AA with t he HSS 
fraction, PGB2 was added to port ions of the ethyl acetate 
fractio n which contained L TB, and evaporated to dryness 
under N2 gas. T he dry residue was redissolved in t he mobile 
phase and injected into t he RP-HPLC system as described in 
Materials and Methods. In t he resul ts shown in Fig 3: (i) T he 
upper HPLC profile shows the detector response at 280 nm to 
authentic standards of PGB2 and L TB, respectively. (ii ) T he 
profi le in t he middle (A) represents t he assayed 1-ml effluents 
collected in t he scintillation vials after the injection of ethyl 
acetate fraction obtained from the incubation of [14C]AA with 
the HSS fraction. App roximately 2.3% of chromatographed 14 C 
comigrated wi th L T B,. (iii) On the other hand, when the HSS 
fraction was incubated wi th [1'C]AA in t he presence of indo-
methac in , t he resul ts showed marked enhancement of polar 
' ''C- labeled metabolites-approximately 11.2% t hat coeluted 
with aut hentic L TB,, as shown in lower profi le (B) . For fu rt her 
veri ficat ion of t he 14C that coeluted with LTB,, port ions of the 
"C containing authent ic L TB, in the ethyl acetate fract ion 
were methylated with diazomethane solut ion and the 14C and 
L TB, methyl esters chromatographed on a SP-HPLC accordi ng 
to Borgeat et al [19]. T he [' ''C) methyl ester cochromatographed 
wit h the methyl ester of aut hentic L TB,. T his system has been 
shown to be effective in separating methyl esters of authent ic 
II ""' \L 
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FIG 3. RP-HPLC of ethyl acetate fractions conta ining 14C- labeled 
metaboli tes , aut hent ic L T B, , and PGB2• HS (105,000 g) supernatant 
fractions (approx 11 00 ;tg protein) were incubated with [14C]AA (0.2 
11Ci), CaC12 (1.5 mM ), and reduced glutathione (1.0 mM ) in t he presence 
or absence of indomethacin (15 ;tM). T he extracted 14C- labeled-metab-
olites were chromatographed fi rst on silicic ac id colu mns as described 
under Materials and Methods. T he ethyl acetate fraction containing 
authentic L TB, and PGB2 was subjected to chromatography on RP-
HPLC. T he H P LC profil e of the ethyl acetate effluent is shown here. 
Tap, HPLC profi le of aut hentic standards of PG 8 2 and L TB, moni tored 
at 280 nm. A, Sequent ial 1-ml aliquots of HP LC fractions assayed for 
rad ioactivity taken from t he incubations of HSS with [14C]AA and no 
indomethacin. B, Sequent ial 1-ml aliquots of HPLC fractio ns assayed 
for radioactivity taken from similar incubations wit h indomethacin. 
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LTB4 from t he nonenzymatically fo rmed di-HETEs. Although 
our exhaustive use of 3 chromatograp hic systems as well as 
derivatizations employed in t hese studies suggest that the ' ''C-
labeled metaboli te from [ 14C]AA is chromatographically similar 
to authentic LTB., the final ident ity of the dihydroxy-radiome-
tabolite may await further resolut ion by GLC-MS. 
DISCUSSION 
The present studies with cell-free preparations confirm pre-
vious observations of t he ex istence of a 12-lipoxygenase path-
way in BALB/c murine keratinocytes (14] . Secondly, our data 
extend this previous observat ion by demonstrating t he addi-
tional ex istence of a 5- lipoxygenase pathway as determined by 
a tracer technique with authentic L TR, (a metabolite of t he 5-
lipoxygenase pathway). These activities are localized mai nly in 
the soluble cytop lasmic fraction prepared from these cell s. The 
occurrence of a 12- lipoxygenase activity in the soluble cyto-
plasmic fraction has also been demonstrated in guinea pig skin 
[20] . Fractionation of J.IC-labeled metabolites and comigration 
with authentic and biologically active L TB. in 3 chromato-
graphic systems seemed reasonable to suggest the existence of 
a 5 -lipoxygenase pathway in t he murine keratinocytes. For-
mation of these 14C- labeled metaboli tes is inhibited by known 
inh ibitors of cyclooxygenase and lipoxygenase pathways 
(ETY A and NDGA) as well as by lipoxygenase inhibitor (15-
HETE). On t he other hand, incubation of t he HSS wi th AA in 
t he presence of indomethacin (a cyclooxygenase inhibitor) en-
hanced the formation of the '"C-labeled lipoxygenase products. 
Althou g h the mechani sm of t his enhanced formation is pres-
ently unclear, it is reasonable to suggest that, at least in part, 
a blockade of the cyclooxygenase pathway by indomethacin 
may increase substrate for metabolism via t he lipoxygenase 
pathway. The significance of the manipulat ion of pathways of 
AA metabolism on the proliferation and differentiation of 
keratinocytes deserves further study. 
The a u t hors express thei r t hanks to Ms. Karen Castelli for typ ing 
of t h e manuscript. 
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